OMER
Omeros Corporation
NASDAQ: OMER · HEALTHCARE · BIOTECHNOLOGY
$14.60
+0.27% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
4.43x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$3 – $18
Volume
1.1M
Omeros Corporation (OMER) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |